Pinnacle Associates’s CorMedix CRMD Stock Holding History

Pinnacle Associates’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,000	Closed	-$37.6K	–	845
2024 Q3	$37.6K	Hold	10,000	–	–	﹤0.01%	794
2024 Q2	$43.3K	Hold	10,000	–	–	﹤0.01%	806
2024 Q1	$42.4K	Hold	10,000	–	–	﹤0.01%	826
2023 Q4	$37.6K	Hold	10,000	–	–	﹤0.01%	809
2023 Q3	$37K	Hold	10,000	–	–	﹤0.01%	805
2023 Q2	$39.6K	Hold	10,000	–	–	﹤0.01%	808
2023 Q1	$41.4K	Hold	10,000	–	–	﹤0.01%	763
2022 Q4	$42.2K	Hold	10,000	–	–	﹤0.01%	750
2022 Q3	$28K	Buy	+10,000	New	+$41.6K	﹤0.01%	732

Other funds holding CRMD

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Elliott Investment Management West Palm Beach, Florida $15.9B AUM 60.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Turn Management Del Mar, California $895M AUM 261.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

J. Goldman & Co New York $2.16B AUM 33.8% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return